Acupuncture for migraine prophylaxis

Linde et al. · Cochrane Database of Systematic Reviews · 2009

📊Cochrane Systematic Review👥n=4,419 participants🏆High-Level Evidence

Evidence Level

STRONG
88/ 100
Quality
5/5
Sample
5/5
Replication
4/5
🎯

OBJECTIVE

To assess whether acupuncture is more effective than usual care and equal or superior to prophylactic medications for migraine prevention

👥

WHO

4,419 patients with a diagnosis of migraine across 22 randomized controlled trials

⏱️

DURATION

Minimum follow-up of 8 weeks, with follow-up of up to 9 months after treatment

📍

POINTS

Treatments ranged from standardized to individualized, with 6-20 sessions of 20-30 minutes each

🔬 Study Design

4419participants
randomization

Acupuncture vs. no treatment

n=2116

6 studies comparing acupuncture with usual care alone

Acupuncture vs. placebo

n=1880

14 studies with sham acupuncture or inadequate points

Acupuncture vs. medications

n=423

4 studies comparing with pharmacologic prophylaxis

⏱️ Duration: 8 weeks to 12 months

📊 Results in numbers

1.43-3.53x

Response vs. usual care

No significant difference

Efficacy vs. placebo

Slightly superior

Efficacy vs. medications

47% fewer

Adverse events vs. medications

Up to 9 months

Durability of effect

Percentage highlights

47% fewer
Adverse events vs. medications

📊 Outcome Comparison

Response rate (>=50% reduction in attacks)

Acupuncture + usual care
55
Usual care alone
25

Adverse events

Acupuncture
15
Prophylactic medications
32
💬 What does this mean for you?

This large Cochrane review shows that acupuncture is effective for preventing migraines when added to usual treatment. The benefit persists for months after the sessions end, with far fewer side effects than preventive medications. Although it was not superior to 'sham' acupuncture, the results suggest it may be a good option for those seeking natural migraine prevention.

📝

Article summary

Plain-language narrative summary

Acupuncture has been used for thousands of years to treat a variety of health conditions, including headaches. For migraine sufferers — a condition that affects millions of people worldwide — finding effective and safe treatments is a constant priority. Migraine is not just an ordinary headache: it consists of recurrent episodes of intense pain, often accompanied by nausea, light and sound sensitivity, that can last from hours to days. Although medications exist to prevent migraine attacks, many carry significant side effects and are not always well tolerated by patients.

For this reason, alternative treatments such as acupuncture have generated significant interest from both patients and clinicians.

This study is a Cochrane systematic review, considered the gold standard in scientific evidence, which rigorously analyzed the efficacy of acupuncture for migraine prevention. The investigators examined 22 randomized controlled clinical trials involving a total of 4,419 participants with a diagnosis of migraine. The primary objective was to investigate whether acupuncture is more effective than not receiving preventive treatment, whether it is superior to sham acupuncture procedures, and whether it is as effective as other proven treatments for reducing migraine attack frequency. The methodology followed rigorous criteria, including only studies with at least 8 weeks of follow-up after treatment, ensuring the results reflected lasting, clinically relevant effects.

The results of this comprehensive analysis revealed an interesting and complex picture of the benefits of acupuncture. When compared with no preventive treatment or only routine care (typically including medications to treat acute attacks), acupuncture demonstrated consistent benefits. Patients who received acupuncture showed superior response rates and lower migraine attack frequency after 3-4 months of treatment. Particularly notable was a long-term study showing sustained benefits up to 9 months after the end of acupuncture treatment.

However, when 'true' acupuncture was compared with sham procedures (with needles inserted at incorrect points or not penetrating the skin adequately), the results showed no statistically significant differences. Strikingly, when compared with proven preventive medications, acupuncture showed slightly superior results and was associated with fewer adverse events, with fewer patients reporting problems and fewer treatment discontinuations due to side effects.

For migraine sufferers and clinicians, these findings have important practical implications. The evidence suggests that acupuncture may be a valuable preventive treatment option, especially for people with frequent migraines or those who do not respond well to conventional medications. Acupuncture appears particularly attractive for patients who prefer to avoid medications because of side effects or who seek a more natural approach to managing their condition. The results indicate that acupuncture benefits can persist for months after the end of treatment, which represents a significant advantage in terms of cost-effectiveness and quality of life.

For clinicians, these data provide a solid scientific basis for recommending acupuncture as a legitimate therapeutic option, especially considering its favorable safety profile compared with preventive medications.

It is important to acknowledge the limitations of this analysis for a balanced interpretation of the results. The fact that 'true' acupuncture did not show clear superiority over sham procedures raises intriguing questions about the mechanisms by which acupuncture may exert its effects. This may suggest that part of the benefit derives from placebo effects amplified by the therapeutic ritual, or that mechanisms not specific to the precise needle placement also contribute to the outcomes. Some included studies had methodological limitations, such as the impossibility of fully blinding treatment when compared with routine care, which may have influenced patient perceptions of outcomes.

In addition, the quality and approach of acupuncture varied considerably across studies, making it difficult to determine which specific techniques are most effective.

In conclusion, this robust systematic review provides consistent evidence that acupuncture offers real benefits in migraine prevention, representing a valuable addition to the available therapeutic armamentarium. Although questions about the specific mechanisms of action remain open, the clinical benefits observed, combined with the excellent safety profile of acupuncture, support its consideration as a viable treatment option. For patients seeking alternatives to preventive medications or who want a complementary approach, acupuncture emerges as a choice supported by solid scientific evidence. Future research should focus on identifying which patients respond best to acupuncture and on optimizing treatment protocols, but the current data already provide sufficient grounds for clinicians to seriously consider this ancient practice as part of a comprehensive migraine management strategy.

Strengths

  • 1Cochrane systematic review with rigorous methodology
  • 2Large number of participants (4,419 patients)
  • 3Consistent evidence of benefit vs. usual care
  • 4Long-term follow-up available
  • 5Fewer adverse events than medications
⚠️

Limitations

  • 1No clear difference vs. sham acupuncture
  • 2Heterogeneity in treatment protocols
  • 3Impossibility of blinding comparisons with usual care
  • 4Possible selection bias in some studies
  • 5Variability in acupuncturist quality
Dr. Marcus Yu Bin Pai

Expert Commentary

Dr. Marcus Yu Bin Pai

MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture

Clinical Relevance

Chronic migraine represents one of the greatest challenges in the pain clinic: patients with multiple monthly attacks, intolerance to beta-blockers, topiramate, or amitriptyline, or simply refractory to first-line agents. This Cochrane review of 4,419 participants consolidates acupuncture as a legitimate prophylactic option for exactly this profile. The figure of 47% fewer adverse events compared with preventive pharmacotherapy is clinically operational — not decorative. For the patient who discontinues propranolol due to symptomatic hypotension or topiramate due to cognitive fog, having an alternative with this safety profile and effect sustained for up to 9 months post-treatment changes the therapeutic conversation. Integration with usual care is also straightforward: acupuncture does not need to replace acute treatment of attacks, and can run in parallel with triptans and NSAIDs during the induction phase of the prophylactic effect.

Notable Findings

The finding that merits attention from colleagues is not the absence of superiority over sham acupuncture — that has been debated for decades — but the slight superiority over prophylactic medications with a dramatically more favorable adverse-event profile. This combination of comparable efficacy and lower dropout due to side effects represents a concrete practical differentiator. Equally noteworthy is the durability of the effect: benefits documented up to 9 months after completing the treatment cycle suggest sustained neuroplastic modulation, consistent with what is known about central sensitization and descending pain modulation mechanisms. In comparisons with usual care, response rates 1.43 to 3.53 times higher demonstrate that this is not a marginal effect but a clinically perceptible reduction in monthly attack burden.

From My Experience

In my practice in the pain clinic, I usually reserve prophylactic acupuncture for two main profiles of migraine patients: those who have already failed at least one pharmacologic line due to intolerance, and those with a cardiovascular contraindication to beta-blockers. In these cases, I start cycles of 10 to 12 weekly sessions, and the pattern I have observed over the years is that the subjective response — reduction in attack frequency and intensity — typically appears between the fourth and sixth session. I routinely combine this with sleep hygiene guidance and trigger management, which considerably amplify the effect. The durability data of up to 9 months matches what I see: many patients maintain their gains with monthly or bimonthly booster sessions, without needing complete repeated cycles. Patients I do not respond well to are those with high analgesic load due to medication overuse — in those, detoxification comes first.

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture.

Full original article

Read the full scientific study

Cochrane Database of Systematic Reviews · 2009

DOI: 10.1002/14651858.CD001218.pub2

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.